Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Use of Zoledronic Acid in Breast Cancer”

7 trials

Showing 7 of 7 results

Not applicableEnded earlyNCT00458796
What this trial is testing

Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone

Who this might be right for
Breast CancerHypercalcemia of MalignancyMetastatic Cancer+2 more
University of Leeds 1,500
Large-scale testing (Phase 3)Study completedNCT00050011
What this trial is testing

Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy

Who this might be right for
Breast NeoplasmsOsteoporosis
Novartis Pharmaceuticals 602
Large-scale testing (Phase 3)UnknownNCT05164952
What this trial is testing

Delayed Versus Immediate Use Of Zoledronic Acid For Postmenopausal Patients With Early Breast Cancer Who Are Using Adjuvant Letrozole

Who this might be right for
Use of Zoledronic Acid in Breast Cancer
Assiut University 50
Large-scale testing (Phase 3)Study completedNCT00512993
What this trial is testing

Postoperative Use of Zoledronic Acid in Breast Cancer Patients After Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
GBG Forschungs GmbH 654
Large-scale testing (Phase 3)Study completedNCT00171340
What this trial is testing

Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.

Who this might be right for
Bone LossBreast Cancer
Novartis Pharmaceuticals 1,065
Large-scale testing (Phase 3)Study completedNCT00107263
What this trial is testing

Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer

Who this might be right for
Breast CancerOsteoporosis
Alliance for Clinical Trials in Oncology 558
Large-scale testing (Phase 3)Study completedNCT00171314
What this trial is testing

The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 527

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation